- Home
- AEVA vs GNFT Comparison
AEVA vs GNFT Comparison
Compare AEVA & GNFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AEVA
- GNFT
- Stock Information
- Founded
- AEVA 2019
- GNFT 1999
- Country
- AEVA United States
- GNFT France
- Employees
- AEVA N/A
- GNFT N/A
- Industry
- AEVA Auto Parts:O.E.M.
- GNFT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AEVA Consumer Discretionary
- GNFT Health Care
- Exchange
- AEVA Nasdaq
- GNFT Nasdaq
- Market Cap
- AEVA 241.9M
- GNFT 202.6M
- IPO Year
- AEVA N/A
- GNFT 2019
- Fundamental
- Price
- AEVA $3.91
- GNFT $3.83
- Analyst Decision
- AEVA Buy
- GNFT Strong Buy
- Analyst Count
- AEVA 5
- GNFT 1
- Target Price
- AEVA $10.53
- GNFT $13.00
- AVG Volume (30 Days)
- AEVA 339.7K
- GNFT 12.7K
- Earning Date
- AEVA 03-04-2025
- GNFT 04-03-2025
- Dividend Yield
- AEVA N/A
- GNFT N/A
- EPS Growth
- AEVA N/A
- GNFT N/A
- EPS
- AEVA N/A
- GNFT 0.47
- Revenue
- AEVA $7,980,000.00
- GNFT $86,225,222.00
- Revenue This Year
- AEVA $109.02
- GNFT $145.20
- Revenue Next Year
- AEVA $63.91
- GNFT N/A
- P/E Ratio
- AEVA N/A
- GNFT $8.08
- Revenue Growth
- AEVA 176.22
- GNFT 175.45
- 52 Week Low
- AEVA $2.20
- GNFT $3.35
- 52 Week High
- AEVA $7.25
- GNFT $6.42
- Technical
- Relative Strength Index (RSI)
- AEVA 39.90
- GNFT 48.44
- Support Level
- AEVA $4.11
- GNFT $3.69
- Resistance Level
- AEVA $4.34
- GNFT $4.03
- Average True Range (ATR)
- AEVA 0.24
- GNFT 0.16
- MACD
- AEVA -0.00
- GNFT -0.00
- Stochastic Oscillator
- AEVA 3.03
- GNFT 24.59
About AEVA Aeva Technologies Inc.
Aeva Technologies Inc through its Frequency Modulated Continuous Wave (FMCW) sensing technology, designs a 4D LiDAR-on-chip that, along with its proprietary software applications, has the potential to enable the adoption of LiDAR across broad applications from automated driving to consumer electronics, consumer health, industrial automation, and security application. The company operates in North America, EMEA, and Asia. The company derives the majority of its revenue from North America.
About GNFT GENFIT S.A.
Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.